That’s the obvious brute force solution, but a possibly more elegant route is just to have an international trials register. This suggestion has been around for a while, and should be significantly less costly (and controversial) than the pre-commit to publishing route while still giving some useful tools for checking on things like publication bias, double publication, etc.
That’s the obvious brute force solution, but a possibly more elegant route is just to have an international trials register. This suggestion has been around for a while, and should be significantly less costly (and controversial) than the pre-commit to publishing route while still giving some useful tools for checking on things like publication bias, double publication, etc.